Overview

Comparative Pharmacokinetic, Pharmacodynamic, and Safety Study of 1 Dose Level of Aspirin for Injection and Oral Aspirin Tablets in Healthy Adult Human Subjects

Status:
Recruiting

Trial end date:
2022-12-15

Target enrollment:

Participant gender:

Summary

The purpose of this study is to compare the safety, pharmacokinetics, and pharmacodynamic effects of aspirin administered intravenously with aspirin administered orally.

Phase:

Phase 1

Details

Lead Sponsor:

Rhoshan Pharmaceuticals Inc

Treatments:

Aspirin